HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norbert Mülleneisen Selected Research

Norbert Mülleneisen Research Topics

Disease

7Hypersensitivity (Allergy)
03/2024 - 12/2018
5COVID-19
11/2022 - 01/2020
2Asthma (Bronchial Asthma)
03/2024 - 01/2017
2Syphilis
04/2021 - 01/2021
1Respiratory Sounds (Crackle)
03/2024
1Fever (Fevers)
03/2024
1Immediate Hypersensitivity
11/2022
1Anaphylaxis (Anaphylactic Shock)
01/2021
1Inflammation (Inflammations)
01/2021
1Peanut Hypersensitivity (Peanut Allergy)
01/2021
1Severe Acute Respiratory Syndrome
01/2021
1Contact Dermatitis (Eczema, Contact)
01/2020
1Drug Hypersensitivity (Drug Allergy)
01/2020
1Aspergillosis
01/2017
1Infections
01/2017

Drug/Important Bio-Agent (IBA)

5VaccinesIBA
11/2022 - 01/2021
3Penicillins (Penicillin)FDA Link
04/2021 - 01/2020
2Anti-Bacterial Agents (Antibiotics)IBA
03/2024 - 01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
03/2024
1Bronchodilator Agents (Bronchodilators)IBA
03/2024
1mRNA VaccinesIBA
11/2022
1Messenger RNA (mRNA)IBA
11/2022
1COVID-19 VaccinesIBA
11/2022
1BNT162 VaccineIBA
01/2021
1AllergensIBA
01/2021
1Epinephrine (Adrenaline)FDA LinkGeneric
01/2021
1beta-LactamsIBA
01/2020
1Cephalosporins (Cephalosporin Antibiotics)IBA
01/2020
1Monoclonal AntibodiesIBA
01/2020
1beta Lactam AntibioticsIBA
01/2020

Therapy/Procedure

3Therapeutics
01/2021 - 01/2017
2Immunotherapy
12/2018 - 01/2017
1Emergency Treatment
01/2021
1Drug Therapy (Chemotherapy)
01/2020